Market evolution: Ophthalmic instruments (CN 901850) — 2015–2025

Introduction

This report analyses the evolution of the European Union's external trade in ophthalmic instruments and appliances (Combined Nomenclature code 901850) between 2015 and 2025. The data reveals a period of robust growth for the EU in this sector, characterized by a significant expansion in trade value and volume, a strengthening trade surplus, and discernible shifts in market structure and geographic orientation. Despite experiencing some supply shocks, the EU has solidified its position as a major net exporter of these specialized medical devices.

1. Sustained Growth and a Strengthening Trade Surplus

The EU's trade in ophthalmic instruments expanded substantially over the decade, with exports consistently outpacing imports in growth, leading to a sharply widened trade surplus.

1.1. Exports Grew Faster Than Imports in Value Terms

Between 2015 and 2025, the total value of EU exports of CN 901850 goods increased by 76.1%, from €793 million to €1.40 billion. Import value grew by 59.3%, from €641 million to €1.02 billion over the same period (General Overview). This differential growth transformed the EU's trade balance from a €152 million surplus in 2015 to a €375 million surplus in 2025, a 146.7% increase.

1.2. Volume Growth Was Driven by Distinct Trends in Sub-Categories

Quantity growth was positive but more modest, with export volume rising by 32.2% and import volume by 33.6%. A closer look at the sub-categories reveals divergent paths:

Import growth was overwhelmingly concentrated in the optical sub-category (CN 90185090), which doubled in volume. Export growth was more balanced but still led by optical instruments (Product Segment Breakdown).

1.3. Export Prices Rose More Steadily Than Import Prices

The average unit value (price) of EU exports increased by 33.1% over the period, from €248,000 per tonne to €331,000 per tonne. The increase for imports was 19.2%, rising from €121,000 to €144,000 per tonne. This price divergence underscores the EU's export focus on higher-value segments of the market.

2. A Diversifying but Shifting Geographic Landscape

The EU's trade relationships for ophthalmic instruments underwent significant evolution, with high-growth partners reshaping the market and altering concentration levels.

2.1. Key Export Partners: China's Ascent and Geopolitical Shifts

While the United States remained the largest single destination for EU exports, growing by 13.7% to €198 million, the most dramatic growth occurred elsewhere.

China became the EU's third-largest export market, with value increasing more than threefold. Exports to Russia also surged, though this trend likely reflects pre-2022 trade and stockpiling, as indicated by a detected price shock in 2022 (Volatility & Shocks).

2.2. Import Sources: Consolidation from Traditional Hubs and New Growth

The United States was the undisputed top source of EU imports, valued at €398 million in 2025. However, the most notable shifts were the rapid growth of imports from China (from €10 million to €44 million, +343%) and Mexico (from €0.1 million to €22 million).

The increase in imports from Switzerland was substantial, rising by 77.6%.

2.3. Market Concentration Declined for Imports but Remained Stable for Exports

The Herfindahl-Hirschman Index (HHI), a measure of market concentration, shows a clear trend. For imports, the HHI fell from 2,939 in 2015 to 2,037 in 2025, a decrease of 30.7%, indicating diversification of the EU's import sources. For exports, the HHI remained broadly stable, at around 880-890, suggesting the EU's export portfolio was already diversified and maintained this characteristic (Market Structure).

3. Specialization, Production, and Market Resilience

Within the EU, production and export specialization are highly concentrated, while the bloc as a whole demonstrates a high degree of export orientation and resilience.

3.1. Production is Concentrated in a Few Key Member States

EU production of ophthalmic instruments (under Prodcom 32.50.13.20) is dominated by a handful of countries. Data for 2025 shows that Belgium (RCA 2.65) and the Netherlands (RCA 1.96) have the strongest Revealed Comparative Advantage (RCA), indicating heavy specialization in this product. Germany, while having a large absolute production share, shows an RCA close to 1 (1.02), meaning its export specialization in this product is in line with its overall export basket (Market Structure).

3.2. The EU is a Net Exporter with High Export Propensity

The EU's net import reliance for this product was negative throughout the period, confirming its status as a net exporter. In 2025, the net reliance stood at -52.4%. More strikingly, the EU's export propensity—the ratio of exports to domestic production—was 134.9% in 2025. This high figure indicates that the EU's ophthalmic instrument industry is fundamentally export-oriented, with a significant portion of its production destined for foreign markets (Autonomy & Vulnerability).

3.3. Geopolitical Events Caused Detectable Trade Shocks

The volatility analysis identifies specific shock events in the time series. A major price shock in exports to Russia in 2022, with an abnormality score of 35.7, likely correlates with the geopolitical and trade disruptions following the invasion of Ukraine. A smaller shock in exports to Australia in 2023, with a price shift of +56.6%, also stands out (Volatility & Shocks).

Conclusion

Over the 2015-2025 period, the EU's market for ophthalmic instruments (CN 901850) demonstrated dynamic growth and structural adaptation. The bloc solidified its position as a major net exporter, significantly widening its trade surplus by leveraging higher-value, optically-intensive product lines. Geographic trade patterns evolved markedly, with China emerging as a critical growth market for EU exports and a rapidly growing source of imports, while traditional partnerships with the US and UK remained foundational. Internally, production and export specialization are concentrated in Belgium, the Netherlands, and Germany, supporting an industry with exceptionally high export propensity. Despite facing shocks from geopolitical turmoil, the EU's trade in this sector has shown resilience and continued expansion, underscoring its competitive strength in specialized medical technology.